or Try an Advanced Search...

    ETF Components for CNBS - Amplify Seymour Cannabis ETF


    Below is a list of stocks held by this ETF. We only list holdings in the same market. If this is a global ETF, there may be additional components other than those listed here.

    Holdings

    Symbol Grade Price % Change Allocation
    IIPR C -1.70 7.93
    TLRY F 0.00 6.39
    GRWG C 1.70 3.43
    MAPS F 2.64 3.42
    SNDL B 1.44 2.09
    REFI D -0.60 1.50
    OGI D 1.17 1.01
    HYFM D -9.73 0.39
    JAZZ D 0.38 0.20
    CARA D -4.32 0.06

    Represented by ETF Holdings

    Keywords: Cannabis Entheogens Euphoriants Medicinal Plants Medicine Aeroponics Biopharmaceutical Cannabis Products Cannabis Smoking Chronic Pain Drugs Health Sciences Herbalism Hydroculture Hydroponics Medical Cannabis Pain Plants Psychoactive Drugs Real Estate Investment Trust
    Industries: Drug Manufacturers - Specialty & Generic Biotechnology Conglomerates Farm & Heavy Construction Machinery Home Improvement Retail REIT - Industrial REIT - Mortgage

    Recent News for Amplify Seymour Cannabis ETF & its Holdings

    Date Stock Title
    Nov 1 TLRY Election 2024: Harris, Trump agree on cannabis policy
    Nov 1 SNDL Cannabis Stock Gainers And Losers From November 1, 2024
    Nov 1 CARA Cannabis Stock Gainers And Losers From November 1, 2024
    Nov 1 CNBS Marijuana rescheduling hearing reportedly delayed
    Oct 31 CARA Cannabis Stock Gainers And Losers From October 31, 2024
    Oct 31 SNDL Cannabis Stock Gainers And Losers From October 31, 2024
    Oct 31 JAZZ Jazz Pharmaceuticals Presents New Data at Psych Congress 2024 Confirming Xywav® (calcium, magnesium, potassium, and sodium oxybates) Oral Solution Treatment Benefits in Narcolepsy and Idiopathic Hypersomnia
    Oct 31 SNDL Cannabis Stocks Sink Amid Broader Market Decline And Election Jitters
    Oct 31 TLRY Cannabis Stocks Sink Amid Broader Market Decline And Election Jitters
    Oct 31 JAZZ Esperion Therapeutics (ESPR) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
    Oct 31 TLRY 3 Stocks That Have Generated Terrifying Returns for Investors Over the Past 5 Years
    Oct 31 TLRY Breckenridge Brewery and University of Colorado Athletics Collaborate on New Limited-Edition Craft Beer
    Oct 31 TLRY Trump, Harris And Cannabis Stocks: Are Election Results Already Priced In?
    Oct 30 JAZZ Jazz Pharmaceuticals (JAZZ) Earnings Expected to Grow: Should You Buy?
    Oct 29 IIPR Innovative Industrial Properties (IIPR) Laps the Stock Market: Here's Why
    Oct 29 TLRY Beyond Beer, Tilray's $1.67 Billion Market Play: Is This Cannabis Giant Still A Smart Buy?
    Oct 29 MAPS WM Technology, Inc. to Announce Third Quarter 2024 Financial Results via Webcast
    Oct 29 TLRY Breckenridge Distillery and Flaviar Partner to Release Dad’s Stash Whiskey in Support of No-Shave November, Raising Funds for Fight Colorectal Cancer (Fight CRC)
    Oct 29 JAZZ With A 10% Return On Equity, Is Jazz Pharmaceuticals plc (NASDAQ:JAZZ) A Quality Stock?
    Oct 28 GRWG GrowGeneration Schedules Third Quarter 2024 Earnings Release Conference Call for November 12, 2024
    The investment seeks to provide investors capital appreciation. The fund will invest at least 80% of its net assets (including investment borrowings) in the securities of companies that derive 50% or more of their revenue from the cannabis and hemp ecosystem. It is an actively managed ETF that seeks to provide investment exposure to global companies principally engaged in the emerging cannabis and hemp ecosystem across one of three classifications. The fund is non-diversified.
    Exchange Traded Funds Cannabis Hemp
    Back to the Main CNBS Page...